Real-World Studies of Biologics for the Treatment of Moderate-to-Severe Asthma

被引：0
|
作者：
Desai, Mauli [1 ]
Haines, Adam [2 ]
Oppenheimer, John J. [3 ]
机构：
[1] Montefiore Med Ctr, Albert Einstein Coll Med, Dept Med, Div Allergy & Immunol, 111 East 210th St, Bronx, NY 10467 USA
[2] Montefiore Med Ctr, Albert Einstein Coll Med, Dept Pediat, Div Allergy & Immunol, 111 East 210th St, Bronx, NY 10467 USA
[3] UMDNJ Rutgers, Dept Med, Div Allergy& Immunol, 110 Bergen St Suite 1, Newark, NJ 07103 USA
来源：
IMMUNOLOGY AND ALLERGY CLINICS OF NORTH AMERICA | 2024年 / 44卷 / 04期
关键词：
Severe asthma; Real-world studies; Omalizumab; Mepolizumab; Reslizumab; Benralizumab; Dupilumab; Tezepelumab; SEVERE EOSINOPHILIC ASTHMA; ALLERGIC-ASTHMA; TEZEPELUMAB-EKKO; OMALIZUMAB; THERAPY; ADULTS; MEPOLIZUMAB; EXACERBATIONS; ADOLESCENTS; DUPILUMAB;
D O I：
10.1016/j.iac.2024.07.007
中图分类号：
R392 [医学免疫学];
学科分类号：
100102 ;
摘要：
[No abstract available]
引用
收藏
页码：737 / 750
页数：14
相关论文
共 50 条
  • [21] Efficacy and Treatment Satisfaction of Different Systemic Therapies in Children and Adolescents with Moderate-to-Severe Atopic Dermatitis: A Real-World Study
    Kiefer, Sebastian
    Koenig, Anke
    Gerger, Viviane
    Rummenigge, Christine
    Mueller, Anne Christine
    Jung, Thomas
    Frank, Alexandra
    Tassopoulos, Georgios
    Laurent, Emilie
    Kaufmann, Roland
    Pinter, Andreas
    JOURNAL OF CLINICAL MEDICINE, 2023, 12 (03)
  • [22] Real-world outcomes of mepolizumab for the treatment of severe eosinophilic asthma in Canada: an observational study
    Chapman, Kenneth R.
    Cogger, Kathryn
    Arthurs, Erin
    LaForty, Callahan
    Golden, Shane
    Millson, Bradley
    Usuba, Koyo
    Licskai, Christopher
    ALLERGY ASTHMA AND CLINICAL IMMUNOLOGY, 2024, 20 (01)
  • [23] Real-world effectiveness of omalizumab for severe allergic asthma treatment in Colombia
    Torres-Duque, Carlos A.
    Ocampo-Gomez, Jaime
    Castillo, Mauricio Morales
    Cano-Rosales, Diana
    Giraldo-Montoya, Angela
    Rodriguez, Freddy
    Palacios-Ortega, Isabel
    Duran-Silva, Mauricio
    Reynales, Humberto
    Garcia, Elizabeth
    BMC PULMONARY MEDICINE, 2022, 22 (01)
  • [24] Cost-effectiveness of omalizumab for the treatment of moderate-to-severe uncontrolled allergic asthma in the United States
    Sullivan, Patrick W.
    Li, Qianyi
    Bilir, S. Pinar
    Dang, Joseph
    Kavati, Abhishek
    Yang, Ming
    Rajput, Yamina
    CURRENT MEDICAL RESEARCH AND OPINION, 2020, 36 (01) : 23 - 32
  • [25] Benefits of biologic therapy administered for asthma on co-existent chronic rhinosinusitis: A real-world study
    Bajpai, Shilpika
    Marino, Michael J.
    Rank, Matthew A.
    Donaldson, Angela M.
    O'Brien, Erin K.
    Lal, Devyani
    INTERNATIONAL FORUM OF ALLERGY & RHINOLOGY, 2021, 11 (08) : 1152 - 1161
  • [26] A real-life comparison of pulmonary and nasal outcomes in patients with severe asthma and nasal polyposis treated with T2-biologics
    Foerster-Ruhrmann, Ulrike
    Stergioudi, Dafni
    Szczepek, Agnieszka J.
    Fluhr, Joachim W.
    Zuberbier, Torsten
    Olze, Heidi
    Bergmann, Karl-Christian
    WORLD ALLERGY ORGANIZATION JOURNAL, 2023, 16 (02):
  • [27] Real-world comparison of T2-biologics effectiveness in severe allergic asthma with nasal polyps
    Tiotiu, Angelica
    Migueres, Nicolas
    Gonzalez-Barcala, Francisco-Javier
    Roux, Pauline
    Oster, Jean-Philippe
    Moutard, Natacha
    de Blay, Frederic
    Bonniaud, Philippe
    RESPIRATORY MEDICINE, 2025, 238
  • [28] Treatment for Severe Asthma in Children: What About Biologics?
    Pansare, Milind
    Seth, Divya
    Kamat, Deepak
    Poowuttikul, Pavadee
    PEDIATRIC ANNALS, 2021, 50 (05): : E206 - E213
  • [29] Mepolizumab for severe eosinophilic asthma: a real-world snapshot on clinical markers and timing of response
    Caminati, Marco
    Cegolon, Luca
    Vianello, Andrea
    Bianchi, Fulvia Chieco
    Festi, Giuliana
    Marchi, Maria R.
    Micheletto, Claudio
    Mazza, Francesco
    Tognella, Silvia
    Sennaon, Gianenrico
    Artioli, Denise
    Bertocco, Elisabetta
    Bonazza, Lucio
    Crivellaro, Mariangiola
    De Conti, Fabio
    Dama, Annarita
    Donazzan, Giulio
    Guarnieri, Gabriella
    Idotta, Giuseppe
    Lombardi, Carlo
    Marino, Luigi
    Nardini, Stefano
    Olivieri, Mario
    Reccardini, Federico
    Schiappoli, Michele
    EXPERT REVIEW OF RESPIRATORY MEDICINE, 2019, 13 (12) : 1205 - 1212
  • [30] Biologics in severe asthma: A pragmatic approach for choosing the right treatment for the right patient
    Rogers, Linda
    Jesenak, Milos
    Bjermer, Leif
    Hanania, Nicola A.
    Seys, Sven F.
    Diamant, Zuzana
    RESPIRATORY MEDICINE, 2023, 218
12345